Cargando…

CKLF as a Prognostic Biomarker and Its Association with Immune Infiltration in Hepatocellular Carcinoma

The Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing (CMTM) family, comprising nine members, is involved in the tumorigenesis and progression of various cancers. However, the expression profiles and clinical significance of CMTM family members in hepatocellular carcinoma (HCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dan, Huang, Shenglan, Luo, Chen, Xu, Yongkang, Fu, Shumin, Liu, Kan, Wu, Jianbing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047849/ https://www.ncbi.nlm.nih.gov/pubmed/36975415 http://dx.doi.org/10.3390/curroncol30030202

Ejemplares similares

ARPC2: A Pan-Cancer Prognostic and Immunological Biomarker That Promotes Hepatocellular Carcinoma Cell Proliferation and Invasion
por: Huang, Shenglan, et al.
Publicado: (2022)

Efficacy and safety of hepatic arterial infusion chemotherapy combined with programmed cell death protein-1 antibody and lenvatinib for advanced hepatocellular carcinoma
por: Xu, Yongkang, et al.
Publicado: (2022)

The Prognostic Value of Lysine Acetylation Regulators in Hepatocellular Carcinoma
por: Sun, Liying, et al.
Publicado: (2022)

A comprehensive prognostic and immunological analysis of ephrin family genes in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Identification of Arp2/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma
por: Huang, Shenglan, et al.
Publicado: (2021)

Prognostic Biomarker DDOST and Its Correlation With Immune Infiltrates in Hepatocellular Carcinoma
por: Zhu, Changyu, et al.
Publicado: (2022)

Lenvatinib Plus PD-1 Inhibitors versus Regorafenib in Patients with Advanced Hepatocellular Carcinoma After the Failure of Sorafenib: A Retrospective Study
por: Xu, Yongkang, et al.
Publicado: (2023)

Key Candidate Prognostic Biomarkers Correlated with Immune Infiltration in Hepatocellular Carcinoma
por: Deng, Zenghua, et al.
Publicado: (2021)

Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma
por: Cai, Xiaopeng, et al.
Publicado: (2021)

CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Luo, Jun-peng, et al.
Publicado: (2021)

Nucleoporin 107 is a prognostic biomarker in hepatocellular carcinoma associated with immune infiltration
por: Nong, Ju‐sen, et al.
Publicado: (2023)

Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma
por: Wang, Yongkang, et al.
Publicado: (2021)

Diagnostic Accuracy of Artificial Intelligence Based on Imaging Data for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Zhang, Jian, et al.
Publicado: (2022)

CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma
por: Gu, Yurong, et al.
Publicado: (2020)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma
por: Wang, Zhen-Zhen, et al.
Publicado: (2022)

A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023)

Corrigendum: A comprehensively prognostic and immunological analysis of actin-related protein 2/3 complex subunit 5 in pan-cancer and identification in hepatocellular carcinoma
por: Huang, Shenglan, et al.
Publicado: (2022)

CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells
por: Li, Wujun, et al.
Publicado: (2017)

MRGBP is a potential novel prognostic biomarker and is correlated with immune infiltrates in hepatocellular carcinoma
por: Huang, Juanjun, et al.
Publicado: (2021)

Comprehensive Analysis of HHLA2 as a Prognostic Biomarker and Its Association With Immune Infiltrates in Hepatocellular Carcinoma
por: Ding, Lin, et al.
Publicado: (2022)

Comprehensive Analysis of NABP2 as a Prognostic Biomarker and Its Correlation with Immune Infiltration in Hepatocellular Carcinoma
por: Li, Bowen, et al.
Publicado: (2023)

DCK is a promising prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
por: Song, Danjun, et al.
Publicado: (2020)

EOGT Correlated With Immune Infiltration: A Candidate Prognostic Biomarker for Hepatocellular Carcinoma
por: Shu, Yang, et al.
Publicado: (2022)

BTBD10 is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Li, Jianhui, et al.
Publicado: (2022)

HSPB11 is a Prognostic Biomarker Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Liu, Hui, et al.
Publicado: (2022)

DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
por: Yuan, Mengping, et al.
Publicado: (2022)

PVR—A Prognostic Biomarker Correlated with Immune Cell Infiltration in Hepatocellular Carcinoma
por: Liu, Wen-Feng, et al.
Publicado: (2022)

Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2022)

BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma
por: Chen, Yi-Ru, et al.
Publicado: (2020)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

Nuf2 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Hepatocellular Carcinoma
por: Xie, Xingwei, et al.
Publicado: (2021)

Identification of Rad51 as a prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Xu, Hao, et al.
Publicado: (2021)

ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Feng, Yuanyuan, et al.
Publicado: (2022)

LPCAT1 acts as an independent prognostic biomarker correlated with immune infiltration in hepatocellular carcinoma
por: Li, Lan, et al.
Publicado: (2022)

Prognostic Value of Complement Component 2 and Its Correlation with Immune Infiltrates in Hepatocellular Carcinoma
por: Ning, Gang, et al.
Publicado: (2020)

A breakdown of metabolic reprogramming in microglia induced by CKLF1 exacerbates immune tolerance in ischemic stroke
por: Ma, Wen-yu, et al.
Publicado: (2023)

ZNF320 is a hypomethylated prognostic biomarker involved in immune infiltration of hepatocellular carcinoma and associated with cell cycle
por: Zhen, Jing, et al.
Publicado: (2022)

Bioinformatics-Based Discovery of CKLF-Like MARVEL Transmembrane Member 5 as a Novel Biomarker for Breast Cancer
por: Zhou, Juan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_uj39j13rt10hn1b7keiif7820q